Adagene's Series B Round

Adagene raised a round of funding on January 28, 2016.

Adagene is a biotechnology company focused on the discovery and development of antibody therapeutics for partner companies and for its own internal pipeline. Adagene's vision is to vastly expand the a…

Articles about Adagene's Series B Round: